Literature DB >> 25212649

Laboratory monitoring of the non-vitamin K oral anticoagulants.

Andrew D Blann1, Gregory Y H Lip2.   

Abstract

Entities:  

Keywords:  apixaban; coagulation tests; dabigatran; monitoring; non-vitamin K oral anticoagulant (NOAC); rivaroxaban

Mesh：

Substances：

Year:  2014        PMID： 25212649     DOI： 10.1016/j.jacc.2014.07.010

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  8 in total

1.  Monitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.

Authors:  Nur A Rahmat; Gregory Y H Lip
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

Review 2.  Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review.

Authors:  Boris Arbit; Jonathan C Hsu
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

3.  Drug Adherence in Patients With Nonvalvular Atrial Fibrillation Taking Non-Vitamin K Antagonist Oral Anticoagulants in Turkey: NOAC-TR.

Authors:  Sadık Volkan Emren; Oktay Şenöz; Murat Bilgin; Osman Beton; Abdullah Aslan; Uğur Taşkin; Gönül Açiksari; Lale Dinç Asarcikli; Hakan Çakir; Lütfü Bekar; İsmail Bolat; Çağrı Yayla; Barış Çelebi; Onur Dalgiç; Oğuzhan Çelik; Özgen Şafak; Serdar Akyel; Hasan Güngör; Barış Düzel; Mehdi Zoghi
Journal:  Clin Appl Thromb Hemost       Date:  2017-02-19       Impact factor: 2.389

4.  Anticoagulation in Atrial Fibrillation - Current Concepts.

Authors:  Demosthenes G Katritsis; Bernard J Gersh; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

5.  Evaluation of the Antithrombotic Effects of Rivaroxaban and Apixaban Using the Total Thrombus-Formation Analysis System®: In Vitro and Ex Vivo Studies.

Authors:  Hidekazu Sugihara; Yoshiaki Idemoto; Takashi Kuwano; Yoshihisa Nagata; Joji Morii; Makoto Sugihara; Masahiro Ogawa; Shin-Ichiro Miura; Keijiro Saku
Journal:  J Clin Med Res       Date:  2016-10-26

Review 6.  Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era.

Authors:  Peter P Toth
Journal:  Vasc Health Risk Manag       Date:  2016-02-10

7.  Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands.

Authors:  Susan Hanemaaijer; Fong Sodihardjo; Annemieke Horikx; Michel Wensing; Peter A G M De Smet; Marcel L Bouvy; Martina Teichert
Journal:  Int J Clin Pharm       Date:  2015-08-05

8.  Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban.

Authors:  Jen-Hung Huang; Yung-Kuo Lin; Cheng-Chih Chung; Ming-Hsiung Hsieh; Wan-Chun Chiu; Yi-Jen Chen
Journal:  Clin Appl Thromb Hemost       Date:  2018-09-24       Impact factor: 2.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.